All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Hepatitis B, Chronic-34920100

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	34920100	C1491G	X	X	Hepatitis B, Chronic Liver Cirrhosis	G R C L	View
2	34920100	C1500T	X	X	Hepatitis B, Chronic Liver Cirrhosis	G R C L	View
3	34920100	G1613T	X	X	Hepatitis B, Chronic Liver Cirrhosis	G R C L	View
4	34920100	G1658T	X	X	Hepatitis B, Chronic Liver Cirrhosis	G R C L	View
5	34920100	P40A	X	X	Hepatitis B, Chronic Liver Cirrhosis	G R C L	View
6	34920100	P43S	X	X	Hepatitis B, Chronic Liver Cirrhosis	G R C L	View
7	34920100	D80E	X	X	Hepatitis B, Chronic Liver Cirrhosis	G R C L	View
8	34920100	K95N	X	X	Hepatitis B, Chronic Liver Cirrhosis	G R C L	View
9	34920100	A1635T	EnhII		Hepatitis B, Chronic Liver Cirrhosis	G R C L	View
10	34920100	A1727T	Core Promoter		Hepatitis B, Chronic Liver Cirrhosis	G R C L	View
11	34920100	A1762T	Core Promoter		Hepatitis B, Chronic Liver Cirrhosis	G R C L	View
12	34920100	C1481T	X	X	Hepatitis B, Chronic Liver Cirrhosis	G R C L	View
13	34920100	C1678T	EnhII		Hepatitis B, Chronic Liver Cirrhosis	G R C L	View
14	34920100	C1773T	Core Promoter		Hepatitis B, Chronic Liver Cirrhosis	G R C L	View
15	34920100	G1479A	X	X	Hepatitis B, Chronic Liver Cirrhosis	G R C L	View
16	34920100	G1512A	X	X	Hepatitis B, Chronic Liver Cirrhosis	G R C L	View
17	34920100	G1764A	Core Promoter		Hepatitis B, Chronic Liver Cirrhosis	G R C L	View
18	34920100	T1498C	X	X	Hepatitis B, Chronic Liver Cirrhosis	G R C L	View
19	34920100	A1633G	EnhII		Hepatitis B, Chronic Liver Cirrhosis	G R C L	View
20	34920100	A1635G	EnhII		Hepatitis B, Chronic Liver Cirrhosis	G R C L	View
21	34920100	A1727G	Core Promoter		Hepatitis B, Chronic Liver Cirrhosis	G R C L	View
22	34920100	A1752C	Core Promoter		Hepatitis B, Chronic Liver Cirrhosis	G R C L	View
23	34920100	A1755G	Core Promoter		Hepatitis B, Chronic Liver Cirrhosis	G R C L	View
24	34920100	A1757G	Core Promoter		Hepatitis B, Chronic Liver Cirrhosis	G R C L	View
25	34920100	A1811T	Core Promoter		Hepatitis B, Chronic Liver Cirrhosis	G R C L	View
26	34920100	A1814T	Core Promoter		Hepatitis B, Chronic Liver Cirrhosis	G R C L	View
27	34920100	C1509T	X	X	Hepatitis B, Chronic Liver Cirrhosis	G R C L	View
28	34920100	C1810T	Core Promoter		Hepatitis B, Chronic Liver Cirrhosis	G R C L	View
29	34920100	C1812T	Core Promoter		Hepatitis B, Chronic Liver Cirrhosis	G R C L	View
30	34920100	C1813T	Core Promoter		Hepatitis B, Chronic Liver Cirrhosis	G R C L	View
31	34920100	C1831T	DR1		Hepatitis B, Chronic Liver Cirrhosis	G R C L	View
32	34920100	G1484C	X	X	Hepatitis B, Chronic Liver Cirrhosis	G R C L	View
33	34920100	G1809T	Core Promoter		Hepatitis B, Chronic Liver Cirrhosis	G R C L	View
34	34920100	T1449C	X	X	Hepatitis B, Chronic Liver Cirrhosis	G R C L	View
35	34920100	T1464C	X	X	Hepatitis B, Chronic Liver Cirrhosis	G R C L	View
36	34920100	T1482C	X	X	Hepatitis B, Chronic Liver Cirrhosis	G R C L	View
37	34920100	T1753G	Core Promoter		Hepatitis B, Chronic Liver Cirrhosis	G R C L	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.